BFB759, Placebo
CL-BFB759-002
Phase 2 small_molecule active
Quick answer
BFB759, Placebo for Atopic dermatitis is a Phase 2 program (small_molecule) at Blue Earth Diagnostics Ireland Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Blue Earth Diagnostics Ireland Ltd
- Indication
- Atopic dermatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active